Lamotrigine
Product Images NDC 50090-2825

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 50090-2825). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Lamotrigine (C76106cb 5861 428c B91e C0f3c0a92472 01)

Structured Formula For Lamotrigine (C76106cb 5861 428c B91e C0f3c0a92472 01)
Chemical structure of Lamotrigine showing a chlorinated benzene ring connected to a triazine ring with amino groups, as submitted by A-S Medication Solutions under NDC 50090-2825.*
FDA Label Image

Lamotrigine Tablet (C76106cb 5861 428c B91e C0f3c0a92472 02)

Lamotrigine Tablet (C76106cb 5861 428c B91e C0f3c0a92472 02)
A Kaplan-Meier failure probability curve comparing lamotrigine and placebo groups over 100 weeks. The y-axis represents failure probability percentage, and the x-axis shows time in weeks. The graph includes censored data points and indicates that the placebo group has a higher failure probability than the lamotrigine group throughout the study period.*
FDA Label Image

Lamotrigine Tablets (C76106cb 5861 428c B91e C0f3c0a92472 03)

Lamotrigine Tablets (C76106cb 5861 428c B91e C0f3c0a92472 03)
A survival failure probability line chart comparing Lamotrigine and placebo over approximately 80 weeks. The x-axis represents time in weeks, and the y-axis shows failure probability percentage. The chart includes censored data points and two distinct step lines labeled 'Lamotrigine' and 'Placebo'.*
FDA Label Image

Structured Formula For Lamotrigine (C76106cb 5861 428c B91e C0f3c0a92472 04)

Structured Formula For Lamotrigine (C76106cb 5861 428c B91e C0f3c0a92472 04)
A table showing the color and identifying embossing details for Lamotrigine tablets ranging from 25 mg to 250 mg strengths. Each entry specifies the tablet color as white to off-white, and notes the numeric embossing on each side of the tablet along with the presence of the letters 'ZC.'*
FDA Label Image

Structured Formula For Lamotrigine (C76106cb 5861 428c B91e C0f3c0a92472 05)

Structured Formula For Lamotrigine (C76106cb 5861 428c B91e C0f3c0a92472 05)
Text describing two forms of Lamotrigine tablets: a 5 mg white to off-white tablet, bisected and debossed with 'Z' on one side and '13' on the other; and a 25 mg white to off-white tablet, debossed with 'Z' and '12' on one side.*
FDA Label Image

Label Image (Lbl500902825)

Label Image (Lbl500902825)
Lamotrigine 25 mg tablet label from A-S Medication Solutions, including NDC 50090-2825-0 and product number 9021-0. Specifies storage conditions at 68 to 77 degrees Fahrenheit, and that each scored tablet contains 25 mg of lamotrigine. The label also references a size 33 unit dose tablet package and includes a QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.